Floatz logo

Lopinavir

Giant Cell Glioblastoma

Case Comprehensive Cancer CenterSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Giant Cell Glioblastoma cohort.

Asset / SponsorPhaseRating
Irinotecan
Case Comprehensive Cancer Center
Phase 2BBB
Cediranib
Lawrence Recht
Phase 2BBB
Temsirolimus
National Cancer Institute (NCI)
Phase 2BBB
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)-
National Cancer Institute (NCI)
Phase 2BB
Sorafenib
National Cancer Institute (NCI)
Phase 2BB

View all 50 →

Same molecule, other indications

Lopinavir is also rated in:

HIV infectious diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
lipodystrophyDormant
BB
Indicative ·
69 / 100
View asset →
DyslipidemiasDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →